+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Post-Traumatic Stress Disorder Treatment Market By Treatment Type, By Age Group, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 245 Pages
  • June 2022
  • Region: Global
  • Allied Market Research
  • ID: 5670759
UP TO OFF until Oct 24th 2024
The global post-traumatic stress disorder treatment market was valued at $15,976.64 million in 2021 and is projected to reach $26,060.75 million by 2031, registering a CAGR of 4.9% from 2022 to 2031. Post-traumatic stress disorder is a serious condition related to mental health. It is caused due to life-threatening events, recurrent anxiety, sex abuse & internal reminder of traumatic events. The symptoms of the disorder include flashbacks, nightmares, swings of mood, changes in physical activities & uncontrollable thoughts about the incident that may cause a stressed condition for the patient. Post-Traumatic Stress Disorder (PTSD) is a mental disorder characterized by disturbing symptoms that interfere with daily functioning. PTSD symptoms may start very quickly following a traumatic event, or they might not appear for years after the event including intrusive memories or reliving of the experience, avoidance of anything that reminds the person of the trauma, negative changes in thinking or mood that are a result of the trauma and which interfere with daily functioning, and changes in the person’s emotional reactions to everyday events.

The global post-traumatic stress disorder treatment market is majorly driven by an increase in the prevalence of post-traumatic stress disorder due to the increase in the number of accidents or incidents across the globe. In addition, an increase in clinical trials and a rise in the geriatric population drives the growth of the market in upcoming years. However, side effects associated with drug treatment are expected to hamper the market. Moreover, the increase in research & development activities for antidepressant drugs against post-traumatic stress disorder, rise in government initiatives for post-traumatic stress disorder treatment management, and increase in healthcare expenditure in developing countries are the key factor that boosts the growth of the market.

The post-traumatic stress disorder treatment market is segmented on the basis of treatment type, age group, end-user, and region. On the basis of treatment type, the market is divided into drugs and psychotherapy. By drugs, the market is classified into antidepressants, antipsychotics, beta-blockers, benzodiazepines, and others. Psychotherapy, the market is divided into cognitive behavior therapy, psychodynamic therapy, and others. On the basis of age, the market is divided into geriatric, pediatric, and adults. By end-user, the market is classified into hospitals, outpatients’ clinics, mental health centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
.The key players operating in the global post-traumatic stress disorder treatment market are Acadia Healthcare, Behavioral Health Network, Inc., CareTech Holdings Plc, GlaxoSmithKline Plc, Pfizer, Inc, Viatris, Inc, Strategic Behavioral Health, Ascension Seton, North Range Behavioral Health, Pyramid Healthcare and Eily Lilly and Company.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the post-traumatic stress disorder treatment market analysis from 2021 to 2031 to identify the prevailing post-traumatic stress disorder treatment market opportunities.
  • The Market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the post-traumatic disorder treatment market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global post-traumatic stress disorder treatment market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Treatment Type

  • Drugs
  • Pyschotherapy

By Age Group

  • Pediartic
  • Geriatric
  • Adult

By End User

  • Mental Health Center
  • Others
  • Hospitals
  • Outpaitent Clinics

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Spain
  • Rest of Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest Of Asia Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Acadia Healthcare
  • Behavioral Health Network, Inc
  • Caretech Holdings PLC
  • GlaxoSmithKline Plc
  • Pfizer, Inc
  • Viatris, Inc
  • Strategic Behavioral Health
  • North Range Behavioral Health
  • Pyramid Healthcare
  • Eily Lilly and Company

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: POST-TRAUMATIC STRESS DISORDER TREATMENT MARKET, BY TREATMENT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Drugs
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Pyschotherapy
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: POST-TRAUMATIC STRESS DISORDER TREATMENT MARKET, BY AGE GROUP
5.1 Overview
5.1.1 Market size and forecast
5.2 Pediartic
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Geriatric
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Adult
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: POST-TRAUMATIC STRESS DISORDER TREATMENT MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Outpaitent Clinics
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Mental Health Center
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Others
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: POST-TRAUMATIC STRESS DISORDER TREATMENT MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Treatment Type
7.2.3 North America Market size and forecast, by Age Group
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Treatment Type
7.2.5.1.2 Market size and forecast, by Age Group
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Treatment Type
7.2.5.2.2 Market size and forecast, by Age Group
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Treatment Type
7.2.5.3.2 Market size and forecast, by Age Group
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Treatment Type
7.3.3 Europe Market size and forecast, by Age Group
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Treatment Type
7.3.5.1.2 Market size and forecast, by Age Group
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Treatment Type
7.3.5.2.2 Market size and forecast, by Age Group
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Treatment Type
7.3.5.3.2 Market size and forecast, by Age Group
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Treatment Type
7.3.5.4.2 Market size and forecast, by Age Group
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Treatment Type
7.3.5.5.2 Market size and forecast, by Age Group
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Treatment Type
7.3.5.6.2 Market size and forecast, by Age Group
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Treatment Type
7.4.3 Asia-Pacific Market size and forecast, by Age Group
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Treatment Type
7.4.5.1.2 Market size and forecast, by Age Group
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Treatment Type
7.4.5.2.2 Market size and forecast, by Age Group
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Treatment Type
7.4.5.3.2 Market size and forecast, by Age Group
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Treatment Type
7.4.5.4.2 Market size and forecast, by Age Group
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Treatment Type
7.4.5.5.2 Market size and forecast, by Age Group
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest Of Asia Pacific
7.4.5.6.1 Market size and forecast, by Treatment Type
7.4.5.6.2 Market size and forecast, by Age Group
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Treatment Type
7.5.3 LAMEA Market size and forecast, by Age Group
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Treatment Type
7.5.5.1.2 Market size and forecast, by Age Group
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Treatment Type
7.5.5.2.2 Market size and forecast, by Age Group
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Treatment Type
7.5.5.3.2 Market size and forecast, by Age Group
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Treatment Type
7.5.5.4.2 Market size and forecast, by Age Group
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Acadia Healthcare
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Behavioral Health Network, Inc
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Caretech Holdings PLC
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 GlaxoSmithKline Plc
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Pfizer, Inc
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Viatris, Inc
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Strategic Behavioral Health
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 North Range Behavioral Health
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Pyramid Healthcare
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Eily Lilly and Company
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
List of Tables
Table 1. Global Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 2. Post-Traumatic Stress Disorder Treatment Market Size, for Drugs, by Region, 2021-2031 ($Million)
Table 3. Post-Traumatic Stress Disorder Treatment Market for Drugs by Country, 2021-2031 ($Million)
Table 4. Post-Traumatic Stress Disorder Treatment Market Size, for Pyschotherapy, by Region, 2021-2031 ($Million)
Table 5. Post-Traumatic Stress Disorder Treatment Market for Pyschotherapy by Country, 2021-2031 ($Million)
Table 6. Global Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 7. Post-Traumatic Stress Disorder Treatment Market Size, for Pediartic, by Region, 2021-2031 ($Million)
Table 8. Post-Traumatic Stress Disorder Treatment Market for Pediartic by Country, 2021-2031 ($Million)
Table 9. Post-Traumatic Stress Disorder Treatment Market Size, for Geriatric, by Region, 2021-2031 ($Million)
Table 10. Post-Traumatic Stress Disorder Treatment Market for Geriatric by Country, 2021-2031 ($Million)
Table 11. Post-Traumatic Stress Disorder Treatment Market Size, for Adult, by Region, 2021-2031 ($Million)
Table 12. Post-Traumatic Stress Disorder Treatment Market for Adult by Country, 2021-2031 ($Million)
Table 13. Global Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 14. Post-Traumatic Stress Disorder Treatment Market Size, for Hospitals, by Region, 2021-2031 ($Million)
Table 15. Post-Traumatic Stress Disorder Treatment Market for Hospitals by Country, 2021-2031 ($Million)
Table 16. Post-Traumatic Stress Disorder Treatment Market Size, for Outpaitent Clinics, by Region, 2021-2031 ($Million)
Table 17. Post-Traumatic Stress Disorder Treatment Market for Outpaitent Clinics by Country, 2021-2031 ($Million)
Table 18. Post-Traumatic Stress Disorder Treatment Market Size, for Mental Health Center, by Region, 2021-2031 ($Million)
Table 19. Post-Traumatic Stress Disorder Treatment Market for Mental Health Center by Country, 2021-2031 ($Million)
Table 20. Post-Traumatic Stress Disorder Treatment Market Size, for Others, by Region, 2021-2031 ($Million)
Table 21. Post-Traumatic Stress Disorder Treatment Market for Others by Country, 2021-2031 ($Million)
Table 22. Post-Traumatic Stress Disorder Treatment Market, by Region, 2021-2031 ($Million)
Table 23. North America Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 24. North America Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 25. North America Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 26. North America Post-Traumatic Stress Disorder Treatment Market, by Country, 2021-2031 ($Million)
Table 27. U.S. Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 28. U.S. Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 29. U.S. Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 30. Canada Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 31. Canada Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 32. Canada Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 33. Mexico Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 34. Mexico Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 35. Mexico Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 36. Europe Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 37. Europe Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 38. Europe Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 39. Europe Post-Traumatic Stress Disorder Treatment Market, by Country, 2021-2031 ($Million)
Table 40. Germany Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 41. Germany Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 42. Germany Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 43. France Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 44. France Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 45. France Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 46. U.K. Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 47. U.K. Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 48. U.K. Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 49. Italy Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 50. Italy Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 51. Italy Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 52. Spain Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 53. Spain Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 54. Spain Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 55. Rest of Europe Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 56. Rest of Europe Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 57. Rest of Europe Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 58. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 59. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 60. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 61. Asia-Pacific Post-Traumatic Stress Disorder Treatment Market, by Country, 2021-2031 ($Million)
Table 62. Japan Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 63. Japan Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 64. Japan Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 65. China Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 66. China Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 67. China Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 68. Australia Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 69. Australia Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 70. Australia Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 71. India Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 72. India Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 73. India Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 74. South Korea Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 75. South Korea Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 76. South Korea Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 77. Rest of Asia-Pacific Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 78. Rest of Asia-Pacific Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 79. Rest of Asia-Pacific Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 80. LAMEA Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 81. LAMEA Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 82. LAMEA Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 83. LAMEA Post-Traumatic Stress Disorder Treatment Market, by Country, 2021-2031 ($Million)
Table 84. Brazil Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 85. Brazil Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 86. Brazil Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 87. Saudi Arabia Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 88. Saudi Arabia Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 89. Saudi Arabia Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 90. South Africa Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 91. South Africa Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 92. South Africa Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 93. Rest of LAMEA Post-Traumatic Stress Disorder Treatment Market, by Treatment Type, 2021-2031 ($Million)
Table 94. Rest of LAMEA Post-Traumatic Stress Disorder Treatment Market, by Age Group, 2021-2031 ($Million)
Table 95. Rest of LAMEA Post-Traumatic Stress Disorder Treatment Market, by End-user, 2021-2031 ($Million)
Table 96. Acadia Healthcare: Company Snapshot
Table 97. Acadia Healthcare: Operating Segments
Table 98. Acadia Healthcare: Product Portfolio
Table 99. Acadia Healthcare: Net Sales
Table 100. Acadia Healthcare: Key Stratergies
Table 101. Behavioral Health Network, Inc: Company Snapshot
Table 102. Behavioral Health Network, Inc: Operating Segments
Table 103. Behavioral Health Network, Inc: Product Portfolio
Table 104. Behavioral Health Network, Inc: Net Sales
Table 105. Behavioral Health Network, Inc: Key Stratergies
Table 106. Caretech Holdings plc: Company Snapshot
Table 107. Caretech Holdings plc: Operating Segments
Table 108. Caretech Holdings plc: Product Portfolio
Table 109. Caretech Holdings plc: Net Sales
Table 110. Caretech Holdings plc: Key Stratergies
Table 111. GlaxoSmithKline plc: Company Snapshot
Table 112. GlaxoSmithKline plc: Operating Segments
Table 113. GlaxoSmithKline plc: Product Portfolio
Table 114. GlaxoSmithKline plc: Net Sales
Table 115. GlaxoSmithKline plc: Key Stratergies
Table 116. Pfizer, Inc: Company Snapshot
Table 117. Pfizer, Inc: Operating Segments
Table 118. Pfizer, Inc: Product Portfolio
Table 119. Pfizer, Inc: Net Sales
Table 120. Pfizer, Inc: Key Stratergies
Table 121. Viatris, Inc: Company Snapshot
Table 122. Viatris, Inc: Operating Segments
Table 123. Viatris, Inc: Product Portfolio
Table 124. Viatris, Inc: Net Sales
Table 125. Viatris, Inc: Key Stratergies
Table 126. Strategic Behavioral Health: Company Snapshot
Table 127. Strategic Behavioral Health: Operating Segments
Table 128. Strategic Behavioral Health: Product Portfolio
Table 129. Strategic Behavioral Health: Net Sales
Table 130. Strategic Behavioral Health: Key Stratergies
Table 131. North Range Behavioral Health: Company Snapshot
Table 132. North Range Behavioral Health: Operating Segments
Table 133. North Range Behavioral Health: Product Portfolio
Table 134. North Range Behavioral Health: Net Sales
Table 135. North Range Behavioral Health: Key Stratergies
Table 136. Pyramid Healthcare: Company Snapshot
Table 137. Pyramid Healthcare: Operating Segments
Table 138. Pyramid Healthcare: Product Portfolio
Table 139. Pyramid Healthcare: Net Sales
Table 140. Pyramid Healthcare: Key Stratergies
Table 141. Eily Lilly and Company: Company Snapshot
Table 142. Eily Lilly and Company: Operating Segments
Table 143. Eily Lilly and Company: Product Portfolio
Table 144. Eily Lilly and Company: Net Sales
Table 145. Eily Lilly and Company: Key Stratergies
List of Figures
Figure 1. Post-Traumatic Stress Disorder Treatment Market Segmentation
Figure 2. Post-Traumatic Stress Disorder Treatment Market,2021-2031
Figure 3. Post-Traumatic Stress Disorder Treatment Market,2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Post-Traumatic Stress Disorder Treatment Market:Drivers, Restraints and Opportunities
Figure 12. Post-Traumatic Stress Disorder Treatment Market,By Treatment Type,2021(%)
Figure 13. Comparative Share Analysis of Drugs Post-Traumatic Stress Disorder Treatment Market,2021-2031(%)
Figure 14. Comparative Share Analysis of Pyschotherapy Post-Traumatic Stress Disorder Treatment Market,2021-2031(%)
Figure 15. Post-Traumatic Stress Disorder Treatment Market,By Age Group,2021(%)
Figure 16. Comparative Share Analysis of Pediartic Post-Traumatic Stress Disorder Treatment Market,2021-2031(%)
Figure 17. Comparative Share Analysis of Geriatric Post-Traumatic Stress Disorder Treatment Market,2021-2031(%)
Figure 18. Comparative Share Analysis of Adult Post-Traumatic Stress Disorder Treatment Market,2021-2031(%)
Figure 19. Post-Traumatic Stress Disorder Treatment Market,By End-user,2021(%)
Figure 20. Comparative Share Analysis of Hospitals Post-Traumatic Stress Disorder Treatment Market,2021-2031(%)
Figure 21. Comparative Share Analysis of Outpaitent Clinics Post-Traumatic Stress Disorder Treatment Market,2021-2031(%)
Figure 22. Comparative Share Analysis of Mental Health Center Post-Traumatic Stress Disorder Treatment Market,2021-2031(%)
Figure 23. Comparative Share Analysis of Others Post-Traumatic Stress Disorder Treatment Market,2021-2031(%)
Figure 24. Post-Traumatic Stress Disorder Treatment Market by Region,2021
Figure 25. U.S. Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 26. Canada Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 27. Mexico Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 28. Germany Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 29. France Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 30. U.K. Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 31. Italy Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 32. Spain Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 33. Rest of Europe Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 34. Japan Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 35. China Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 36. Australia Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 37. India Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 38. South Korea Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 39. Rest of Asia-Pacific Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 40. Brazil Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 41. Saudi Arabia Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 42. South Africa Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 43. Rest of LAMEA Post-Traumatic Stress Disorder Treatment Market,2021-2031($Million)
Figure 44. Top Winning Strategies, by Year
Figure 45. Top Winning Strategies, by Development
Figure 46. Top Winning Strategies, by Company
Figure 47. Product Mapping of Top 10 Players
Figure 48. Competitive Dashboard
Figure 49. Competitive Heatmap of Top 10 Key Players
Figure 50. Acadia Healthcare.: Net Sales ,($Million)
Figure 51. Behavioral Health Network, Inc.: Net Sales ,($Million)
Figure 52. Caretech Holdings PLC.: Net Sales ,($Million)
Figure 53. GlaxoSmithKline PLC.: Net Sales ,($Million)
Figure 54. Pfizer, Inc.: Net Sales ,($Million)
Figure 55. Viatris, Inc.: Net Sales ,($Million)
Figure 56. Strategic Behavioral Health.: Net Sales ,($Million)
Figure 57. North Range Behavioral Health.: Net Sales ,($Million)
Figure 58. Pyramid Healthcare.: Net Sales ,($Million)
Figure 59. Eily Lilly and Company.: Net Sales ,($Million)

Executive Summary

According to the report, titled, “Post Traumatic Stress Disorder Treatment Market" the Post Traumatic Stress Disorder Treatment Market size was valued at $16.0 billion in 2021, and is estimated to reach $26.1 billion by 2031, growing at a CAGR of 4.9% from 2022 to 2031.

Post-traumatic stress disorder (PTSD) is a mental health condition triggered by either experiencing it or witnessing it. Post-traumatic stress disorder treatment help to improve in patient’s thinking power, changes in physical activity & regains a sense of control over life. The mode of treatment applied for post-traumatic stress disorder includes medication, therapies, self-care & nutrition.

Post Traumatic Stress Disorder Treatment Market trends are a rise in the prevalence of violent incidents, accidents, and occupational hazards, an increase in research & development activities for drug therapies, rise in the initiative are taken by the government for post-traumatic stress disorder treatment accelerate the Post Traumatic Stress Disorder Treatment Market growth. Moreover, the increase in demand for post-traumatic stress disorder treatment drugs, and the surge in the number of mental and physical abuse cases across the world are the Post Traumatic Disorder Treatment Market trends that drive the growth of the post-traumatic stress disorder treatment market. However, side effects associated with drugs are expected to hamper the growth of the Post Traumatic Stress Disorder Treatment Market.

COVID-19 Impact

The COVID-19 impact has had a positive impact on the post-traumatic stress disorders due to the surge in product sales for maintaining post-traumatic stress conditions. According to a survey conducted by WHO, about 60% of the high-income countries provided telemedicine and teletherapy consultation to patients with severe symptoms of post-traumatic stress disorder. Pharmaceutical Companies amid the pandemic focused on maintaining a balance between supply and demand thus keeping their drug sale intact. Furthermore, during the pandemic large number of patients witnessed a decline in psychotherapies due to COVID-19 which led to rising in the adoption of drugs and medication intended for the treatment of the post-traumatic disorder treatment market. For instance, in 2020, prescription drugs for stress anxiety and post-traumatic disorder spiked up to 18 % respectively, which lead to the tremendous growth of the market.

Post Traumatic Stress Disorder Treatment Market is segmented on the basis of treatment type, age group, end-user, and region. On the basis of treatment type, the market is divided into drugs and psychotherapy. By drugs, the market is classified into antidepressants, antipsychotics, beta-blockers, benzodiazepines, and others. By psychotherapy, the market is divided into cognitive behavior therapy, psychodynamic therapy, and others. On the basis of age, the market is divided into geriatric, pediatric, and adults. By end-user, the market is classified into hospitals, outpatients’ clinics, mental health centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By treatment type, the psychotherapy segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to a rise in the prevalence of post-traumatic stress disorder, and advancements in therapies for post-traumatic stress disorder treatment.

On the basis of age group, the market is classified into children & adults. The adult segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to an increase in the number of road accidents and injuries and an increase in the number of mental and sexual abuse cases among the adults driving the growth of the market.

On the basis of end-user, it is classified into hospitals, outpatient clinics and mental health centers. The hospital segment has the largest Post Traumatic Stress Disorder Treatment Market share in 2021 and is expected to continue this trend during the forecast period, owing to an increase in the number of patients visiting hospitals for post-traumatic stress disorder treatment therapy.

North America accounted for a majority of the global Post Traumatic Stress Disorder Industry share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to its well-established healthcare infrastructure, rise in prevalence of post-traumatic stress disorder, presence of key players, and increase in the volume of medical waste in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to an increase in the prevalence of chronic diseases, a rise in the geriatric population, an increase in demand for healthcare products & services, and rise in a number of hospitals and clinics.

The key players operating in the global post-traumatic stress disorder treatment market are Acadia Healthcare, Behavioral Health Network, Inc., CareTech Holdings Plc, GlaxoSmithKline Plc, Pfizer, Inc, Viatris, Inc, Strategic Behavioral Health, Ascension Seton, North Range Behavioral Health, Pyramid Healthcare and Eily Lilly and Company.

Key Findings of the Study

  • By treatment type, the Psychotherapy segment was the highest contributor to the market in 2021.
  • By age group, the adult segment was the highest contributor to the market in 2021.
  • By end-user, the hospital segment dominated the market in 2021 and is expected to continue this trend during the forecast period.
  • By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

  • Acadia Healthcare
  • Behavioral Health Network, Inc
  • Caretech Holdings plc
  • GlaxoSmithKline plc
  • Pfizer, Inc
  • Viatris, Inc
  • Strategic Behavioral Health
  • North Range Behavioral Health
  • Pyramid Healthcare
  • Eily Lilly and Company

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information